Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sardinian Antiviral Research CfiledCriticalSardinian Antiviral Research C
Priority to IT95CA000010ApriorityCriticalpatent/IT1281503B1/en
Publication of ITCA950010A0publicationCriticalpatent/ITCA950010A0/en
Publication of ITCA950010A1publicationCriticalpatent/ITCA950010A1/en
Application grantedgrantedCritical
Publication of IT1281503B1publicationCriticalpatent/IT1281503B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The use of pyrrolobenzothiadiazepine (BTDP) combinations with nucleoside analogues such as AZT, ddI, ddC, d4T and their phosphodiester and phosophotriester derivatives for the preparation of pharmaceutical compositions suitable for the treatment of AIDS.
IT95CA000010A1995-06-131995-06-13Pyrrolobenzothiadiazepine combinations with nucleoside analogues for the treatment of AIDS
IT1281503B1
(en)
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives, process for their preparation, intermediates of the preparation and pharmaceutical compositions thereof
Acyclic nucleoside derivatives, process for producing them, pharmaceutical compositions containing them and method for the treatment of viral infections